Screening of hypoglycemic activity of herbal mixtures (message ІІ)
DOI:
https://doi.org/10.24959/ubphj.20.281Keywords:
herbal mixtures, hypoglycemic activity, diabetes mellitusAbstract
Topicality. Diabetes mellitus is an important social and medical problem, as it causes the development of dangerous complications that lead to disability and mortality. This disease is characterized by a multi-vector pathogenesis that requires a comprehensive approach to treatment. Due to the use of mixtures of medicinal plants in the treatment of diabetes, it is possible to cover all aspects of the development of this disease and its complications. In addition, the niche of the pharmaceutical market of Ukraine with phytomixtures is almost empty.
Aim. To study the hypoglycemic activity of the herbal mixtures, which are used in folk medicine for diabetes mellitus type 2 prevention and treatment, but do not have a scientific basis and to establish their conditional therapeutic dose.
Materials and methods. The study has been performed in male albino rats weighing 180-200 g, during 20 days they have been receiving orally for preventive treatment aqueous extracts (1:10) of the studied herbal mixtures at a dose 6 mL/kg/day, 9 mL/kg/day and 12 mL/kg/day and comparison drugs – the official herbal mixtures “Arfazetin” at a dose 9 mL/kg/day and tablets metformin at a dose 60 mg/kg/day. The study of hypoglycemic properties and the establishment of a conditional therapeutic dose of the studied mixtures was carried out using glucose loading tests. All experiments have been performed in accordance with general ethical principles with the recommendations of the EEC Council directive 2010/63/EU about the protection of animals used for scientific experiment.
Results and discussion. The results of the study showed the 20-day preventive treatment by the herbal mixtures reduced alimentary hyperglycemia at the 30th minutes of OGTT and helped regulate carbohydrate tolerance disorders by reducing hyperglycemia at the 15th minutes of IPGTT. The highest hypoglycemic activity showed the herbal mixture No. 7 in a dose 12 mL/kg/day, which was almost on a par with the comparison drug – tablets metformin, but exceeded the official herbal mixture “Arfazetin”. In addition, the dose-dependence of the effectiveness of all five studied herbal mixtures was established.
Conclusions. For the first time, it was conducted the screening study of hypoglycemic activity of the herbal mixtures, which are used in folk medicine for the prevention and treatment of diabetes mellitus type 2. It was determined that the greatest effectiveness in terms of the ability to reduce alimentary hyperglycemia during OGTT and reduce impaired carbohydrate tolerance during IPGTT show the herbal mixture No. 7, which includes Inulae rhizomata et radices, Helichrysi arenarii flores, Maydis style cum sigmatis, Origani herba, Rosae fructus, Taraxaci radices. It was established its conditional therapeutic dose 12 mL/kg/day.References
American Diabetes Association. (2020). Standards of medical care in diabetes. Diabetes care, 43, 1212. Available at: https://care.diabetesjournals.org/content/diacare/suppl/2019/12/20/43.Supplement_1.DC1/Standards_of_Care_2020.pdf.
International Diabetes Federation. (2019). IDF Diabetes Atlas. 9th ed. Brussels, Available at: https://www.diabetesatlas.org.
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L. et al. (2017). Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes, 66 (2), 241‐255. doi: https://doi.org/10.2337/db16-0806.
Ndjaboue, R., Farhat, I., Ferlatte, C. A., Ngueta, G., Guay, D., Delorme, S. et al. (2020). Predictive models of diabetes complications: protocol for a scoping review. Systematic reviews, 9 (1), 137. doi: https://doi.org/10.1186/s13643-020-01391-w.
Gothai, S., Ganesan, P., Park, S., Fakurazi, S., Choi, D., Arulselvan, P. (2016). Natural phyto-bioactive compounds for the treatment of type 2 diabetes: inflammation as a target. Nutrients, 8 (8), 461. doi: https://doi.org/10.3390/nu8080461.
Governa, P., Baini, G., Borgonetti, V., Cettolin, G., Giachetti, D., Magnano, A. R., et al. (2018) Phytotherapy in the management of diabetes: a review. Molecules, 23 (1), 105. doi: https://doi.org/10.3390/molecules23010105.
Kooti, W., Farokhipour, M., Asadzadeh, Z., Ashtary-Larky, D., Asadi-Samani, M. (2016). The role of medicinal plants in the treatment of diabetes: a systematic review. Electronic physician, 8 (1), 1832–1842. doi: https://doi.org/10.19082/1832.
Savych, A. O., Marchyshyn, S. M., Kozyr, H. R., Skrinchuk, O. Y. (2019). Osnovni pryntsypy vykorystannya likarskykh roslyn ta yikh zboriv dlya likuvannya ta profilaktyky tsukrovoho diabetu 2 typu. Journal Phypotherapy, 4, 43-46. doi: https://doi.org/10.33617/2522-9680-2019-4-43.
Savych, A., Marchyshyn, S., Basaraba, R., Lukanyuk, M. (2020). Antihyperglycemic, hypolipidemic and antioxidant properties of the herbal mixtures in dexamethasone-induced insulin resistant rats. PharmacologyOnLine, 2, 73-82.
Tovstuha, Ye. S. (2010). Zoloti retsepty ukrayinskoyi narodnoyi medytsyny. Kyiv: Kraina Mriy Publishers, 550.
World Health Organization. (2003). WHO Guidelines on good agricultural and mixture practices (GACP) for medicinal plants. Geneva, Switzerland, 72.
EEC. (2010).”Council directive 2010/63/EU, of the 22nd September 2010 on the approximation of laws, regulations and administrative provisions of the member states regarding the protection of animals used for experimental and other scientific purposes”. Offical Journal of the European Communities, 1–29.
Savych, A., Marchyshyn, S. (2017). Investigation of pharmacological activity the new antidiabetic plant gathering in streptozotocin-nicotinamide-induced diabetes in the rats. The Pharma Innovation Journal, 6 (3), 175-177.
Horakova, O., Kroupova, P., Bardova, K., Janovska, P., Kopecky J. et al. (2019). Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport. Scientific Reports, 9, 6156. doi: https://doi.org/10.1038/s41598-019-42531-0.
Stefanov, O. V. (2001). Doklinichni doslidzhennya likarskykh zasobiv: Metodychni rekomendatsiyi. Kyiv: Avitsena Publishers, 528.
Kietsiriroje, N., Kanjanahirun, K., Kwankaew, J., Ponrak, R., Soonthornpun, S. (2018). Phytosterols and inulin-enriched soymilk increases glucagon-like peptide-1 secretion in healthy men: double-blind randomized controlled trial, subgroup study. BMC research notes, 11 (1), 844. doi: https://doi.org/10.1186/s13104-018-3958-5.
Paternoster, S., Falasca, M. (2018). Dissecting the physiology and pathophysiology of glucagon-like peptide-1. Frontiers in Endocrinology, 9, 584. doi: https://doi.org/10.3389/fendo.2018.00584.
Kang, G. G., Francis, N., Hill, R., Waters, D., Blanchard, C., Santhakumar, A. B. (2019). Dietary polyphenols and gene expression in molecular pathways associated with type 2 diabetes mellitus: A Review. International Journal of Molecular Sciences, 21 (1), 140. doi: https://doi.org/10.3390/ijms21010140.
Adisakwattana, S. (2017). Cinnamic acid and its derivatives: mechanisms for prevention and management of diabetes and its complications. Nutrients, 9 (2), 163. doi: https://doi.org/10.3390/nu9020163.
Sarian, M. N., Ahmed, Q. U., Mat So’ad, S. Z., Alhassan, A. M., Murugesu, S., Perumal, V., et al. (2017). Antioxidant and antidiabetic effects of flavonoids: a structure-activity relationship based study. BioMed research international, 2017, 8386065. doi: https://doi.org/10.1155/2017/8386065.
Panche, A. N., Diwan, A. D., Chandra, S. R. (2016). Flavonoids: an overview. Journal of nutritional science, 5, e47. doi: https://doi.org/10.1017/jns.2016.41.
Kaurinovic, B., Vastag, G. (2019). Flavonoids and phenolic acids as potential natural antioxidants, Antioxidants, Emad Shalaby, IntechOpen. doi: https://doi.org/10.5772/intechopen.83731.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
